enabling news
Press Release: Olympus and evorion Join Forces to Advance Cell Therapy Research
Partnership combines microfluidics, 3D live-cell imaging and AI in an accessible workflow solution HAMBURG/MÜNSTER, Germany, (March 8,...
Press Release – Announcing the appointment of top industry leaders to our supervisory board
Münster July 8, 2021 evorion biotechnologies GmbH, the pioneering developer of technologies for functional phenomics, announced today the...
Launch of custom development services – Accelerate adoptive cell therapy development
The success of any adoptive cell therapy lies in how effectively and selectively engineered immune cells interact with cancer cells to induce...
We’re in the press
European Biotechnology Magazine – Accelerate development of adoptive cell therapies
Check out the article about our functional phenomics technology in the 2021's Autumn Edition of the European Biotechnology Magazine. It can also be...
Transkript magazine – cellular interactions in focus
Our functional phenomics technology was shared in 2021s 3rd issue of the biotechnology magazine transkript. Check it out and learn how our unique...
Interview with CEO Sebastian Bühren in transkript Laborwelt
Transkript Laborwelt featured an interview with our CEO Sebastian Bühren, talking about a new dimension of cellular analysis. Read here (german)...
